ZNL-28693-53924
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Pfizer-BioNTech
- 2021-02-06
- 2021-02-07
- 2021-02-08
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-08-28
Survey response — 6 months, dose 2MedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Various colds, stomach bug since last check inMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2021-10-14
-
2021-10-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-16
- 2021-10-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Various colds, stomach bug since last check in
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release